Hepatitis C treatment has undergone a remarkable transformation New antiviral medications offer shorter more effective ...

Q4 2024 Earnings Call Transcript February 20, 2025 Dynavax Technologies Corporation reports earnings inline with expectations ...

Most of the discussion on the Senate floor on Friday came from lawmakers arguing against passage of the bill, but the passage ...

Dynavax Technologies Corporation ( NASDAQ: DVAX) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Paul Cox - Vice President, Investor Relations & Corporate Communications Ryan Spencer - ...

Atomwise, a leader in leveraging machine learning and artificial intelligence (ML/AI) to advance small molecule drug discovery, today announced the appointment of Steve Worland, Ph.D. as Chief ...

Good day, ladies and gentlemen, and welcome to the Dynavax Technologies fourth quarter and full year 2024 financial results ...

Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu ...

Senate panel approved a $7M contract boost for CoreCivic after fining the private prison company nearly $30M for contract ...

Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...

On the eve of the vote in the West Virginia Senate scheduled today on whether to grant broad religious and philosophical ...

To McIntosh, the most surprising bankruptcy of 2024 was Eiger BioPharmaceuticals, a metabolic disease biotech that was ...

Through his public-benefit corporation Star Syringe, Koska first needed to embark on a public policy and advocacy campaign to ...